سعر فيروسانول جين 30 كبسولة 2025

Hard capsules containing ferrous glycine sulphate complex 454.13 mg and folic acid 1 mg, pack of 30 (3 strips x 10); Minapharm under licence of Schwarz.

• Treatment of combined iron and folic acid deficiency, particularly during pregnancy and breast-feeding and in malnutrition (adults and children from 6 years, at least 20 kg).Teofarma S.r.l. (marketing authorisation holder, Germany)

• Common: gastrointestinal complaints, diarrhoea, constipation, heartburn, vomiting and nausea (more frequent at higher doses). Dark stools due to iron are harmless.International label, same formulation · Teofarma S.r.l. (marketing authorisation holder, Germany)
• Rare: central nervous disturbances at high doses, reversible tooth discolouration, hypersensitivity reactions (rash, exanthema, urticaria). Frequency not known: abdominal pain, gastrointestinal bleeding, reversible discolouration of tongue or oral mucosa, anaphylactic reaction.International label, same formulation · Teofarma S.r.l. (marketing authorisation holder, Germany)

• Hypersensitivity to the active substances or excipients; oesophageal stricture.International label, same formulation · Teofarma S.r.l. (marketing authorisation holder, Germany)
• Iron overload or utilisation disorders: hereditary haemochromatosis (types 1-4), secondary haemosiderosis (chronic haemolysis with iron overload, thalassaemia, other haemoglobinopathies), sideroachrestic or lead anaemias, repeated or chronic blood transfusions.International label, same formulation · Teofarma S.r.l. (marketing authorisation holder, Germany)
• Megaloblastic anaemia due to isolated vitamin B12 deficiency; children under 6 years or under 20 kg.International label, same formulation · Teofarma S.r.l. (marketing authorisation holder, Germany)

• Use with caution in inflammatory bowel disease, intestinal strictures, diverticula, gastritis and gastric or intestinal ulcers.International label, same formulation · Teofarma S.r.l. (marketing authorisation holder, Germany)
• Exclude vitamin B12 deficiency before treating megaloblastic anaemia of unclear cause; folic acid alone may mask B12 deficiency.International label, same formulation · Teofarma S.r.l. (marketing authorisation holder, Germany)
• Iron preparations can cause poisoning, especially in children.International label, same formulation · Teofarma S.r.l. (marketing authorisation holder, Germany)

• Intravenous iron preparationsConcomitant IV and oral iron may cause hypotension or collapse from rapid iron release and transferrin saturation; the combination is not recommended.Teofarma S.r.l. (marketing authorisation holder, Germany)
• Fluoroquinolones (e.g. ciprofloxacin, levofloxacin)Iron strongly reduces fluoroquinolone absorption; take the fluoroquinolone at least 2 hours before or 4 hours after the capsule.Teofarma S.r.l. (marketing authorisation holder, Germany)
• TetracyclinesMutual reduction of absorption; avoid doxycycline with this product and separate other tetracyclines by at least 3 hours.Teofarma S.r.l. (marketing authorisation holder, Germany)

• Iron and folic acid preparations are well established for treating deficiency in pregnancy; controlled studies with up to 5 mg folic acid daily showed no harm to embryo or fetus, and folic acid supplementation may reduce neural tube defect risk. May be used at the recommended dose in pregnancy.International label, same formulation · Teofarma S.r.l. (marketing authorisation holder, Germany)
• May be used during breast-feeding at the recommended dose to treat combined iron and folic acid deficiency.International label, same formulation · Teofarma S.r.l. (marketing authorisation holder, Germany)

• Ferrous glycine sulfate complex: Supplies bioavailable ferrous iron to correct iron deficit: haemoglobin normalises first, then body iron stores are replenished (German SmPC 5.1).
• Folic acid: Active as reduced tetrahydrofolic acid, a carrier of one-carbon groups central to intermediary metabolism of all cells (German SmPC 5.1).